Intelligent Medicine Acquisition Corp. (IQMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Intelligent Medicine Acqu...

    NASDAQ: IQMD · Real-Time Price · USD
    11.04
    0.79 (7.71%)
    At close: Sep 17, 2024, 10:00 PM

    Intelligent Medicine Acquisition Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022
    Period Ending Dec 31, 2022
    Revenue
    		 n/a
    Cost of Revenue
    		 n/a
    Gross Profit
    		 n/a
    Operating Income
    		 n/a
    Interest Income
    		 n/a
    Pretax Income
    		 11.97M
    Net Income
    		 11.41M
    Selling & General & Admin
    		 1.28M
    Research & Development
    		 n/a
    Other Expenses
    		 n/a
    Operating Expenses
    		 1.28M
    Interest Expense
    		 n/a
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 1.28M
    Income Tax Expense
    		 562.57K
    Shares Outstanding (Basic)
    		 23.29M
    Shares Outstanding (Diluted)
    		 23.29M
    EPS (Basic)
    		 0.49
    EPS (Diluted)
    		 0.49
    EBITDA
    		 -14.54M
    EBIT
    		 -14.54M
    Depreciation & Amortization
    		 n/a

    Add to Watchlist